Navigation Links
Survival of the females
Date:12/18/2012

Because of the process involved in the formation of sperm cells, there should be an equal chance that a mammalian egg will be fertilized by "male" sperm, carrying a Y chromosome, as by a "female" sperm, carrying an X chromosome. The symmetry of the system ensures that roughly the same number of males and females are born, which is clearly helpful for the species' long-term survival.

Surprisingly, though, many mammals do not produce equal numbers of male and female offspring. The discrepancy could theoretically be explained by differential fertilization efficiencies of male and female sperm (Y chromosomes are smaller than X chromosomes so perhaps male sperm can swim faster?) or by different rates of survival of male and female foetuses in the uterus. Indeed, it does seem as though male embryos are better able to survive under conditions of high energy intake. But how does this work?

Jana Beckelmann in Christine Aurich's laboratory at the University of Veterinary Medicine, Vienna now presents provocative evidence that a particular protein, insulin-like growth factor-1 or IGF1, might somehow be involved. From an examination of about 30 embryos, Beckelmann noticed that during early pregnancy (between eight and twelve days after fertilization) the level of messenger RNA encoding IGF1 was approximately twice as high in female embryos as in male embryos.

The difference could relate to the fact that female embryos have two X chromosomes, which might produce more of a factor required for the expression of the IGF1 gene (which is not encoded on the X chromosome) than the single X chromosome in males is able to generate. Beckelmann was also able to confirm that the IGF1 protein was present in the embryos, confirming that the messenger RNA is actually translated to protein.

IGF1 is known to have important functions in growth and to inhibit apoptosis, or programmed cell death. As IGF1 treatment of cattle embryos produced in vivo improves their survival, it is likely that the factor has positive effects on the development of the early embryo in the horse. So why should female embryos contain more of the factor than males?

Losses in early pregnancy are unusually high in the horse and it is believed that female embryos are especially prone to spontaneous abortion. Male embryos are known to be better able to survive under high glucose concentrations, so well-nourished mares preferentially give birth to male foals.

As Beckelmann says, "We think the higher IGF1 concentrations in female embryos might represent a mechanism to ensure the survival of the embryos under conditions that would otherwise strongly favour males." If this is so, the ratio of the sexes in horses is the result of a subtle interplay between environmental and internal factors, including insulin-like growth factor-1.


'/>"/>
Contact: Prof. Christine Aurich
christine.aurich@vetmeduni.ac.at
43-664-602-576-400
University of Veterinary Medicine -- Vienna
Source:Eurekalert

Related medicine news :

1. Olympic Medalists May Also Claim Survival Advantage
2. Avastin Wont Extend Breast Cancer Survival: Study
3. UT MD Anderson study finds link between statins and improved survival in inflammatory breast cancer
4. Chemo May Extend Survival After Breast Cancers Return
5. PET imaging used to more accurately manage treatment, predict survival for patients with gliomas
6. Strong Social Support Seems to Boost Breast Cancer Survival
7. Study shows bone metastases treatment can improve overall survival
8. Smart drug improves survival in older patients with acute myeloid leukemia
9. Black patients with kidney cancer have poorer survival than whites
10. High-quality personal relationships improve survival in women with breast cancer
11. Higher dietary glycemic load linked to worse colon cancer survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... For many women, getting birth control isn’t as easy as it should be. In fact, ... to a health care facility or a pharmacy within 60 minutes of where they live. ... for many who are faced with health or personal issues that leave them homebound. To ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... to be invited to the Siemens Healthineers annual customer education symposium, a world-class ... will take place from March 27 - 31, 2017 at the Atlanta Marriott ...
(Date:3/28/2017)... ... ... Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of the world, is ... about journey and research recently on a blog and discussed some major aspects of ... deal with thyroid disease. , Dr. Wentz completed her graduation from the Midwestern ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... medical society dedicated to advancing the science and clinical practice of radiosurgery, ... RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data collection ...
(Date:3/28/2017)... ... 28, 2017 , ... Z-Medica, LLC, a leading developer and ... (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 ... efforts by the American College of Surgeons, U.S. Department of Defense, Department of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... CITY, Calif. , March 28, 2017 /PRNewswire/ ... company focused on the development and commercialization of ... pain, announced that the European Medicines Agency (EMA) ... sublingual tablet, 30 mcg) Marketing Authorisation Application (MAA) ... of the MAA is underway. The MAA for ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 The ... reach USD 8.0 billion by 2025, according to a ... incidence of infectious diseases and cancer is expected to ... disease diagnosis over the coming years. In addition, higher ... autologous and allogenic stem cell therapy, due to adverse ...
Breaking Medicine Technology: